Paul L. Alpern, VP and General Counsel of Arteris, Inc. (NASDAQ:AIP), filed a Form 4 on September 3, 2026, reporting the exercise of incentive stock options and the sale of 4,000 shares of common stock on September 1, 2026.

Key Highlights

  • Option exercise: Alpern exercised an incentive stock option for 4,000 shares of common stock at an exercise price of $0.56 per share on September 1, 2026.
  • Shares sold: 4,000 shares of common stock were disposed of on September 1, 2026, at a weighted average sale price of $20.7658 per share.
  • Sale price range: The 4,000 shares were sold in multiple transactions at prices ranging from $20.61 to $21.38, inclusive.
  • Remaining ownership: Following the transactions, Alpern directly holds 70,733 shares of common stock and 49,000 incentive stock options.
  • 10b5-1 plan: Both transactions were made pursuant to a 10b5-1 trading plan adopted by Alpern on February 23, 2026.

Arteris General Counsel Exercises Options and Sells Stock Under Pre-Planned Trading Program

According to the filing, Paul L. Alpern, who serves as VP and General Counsel of Arteris, Inc., executed two related transactions on September 1, 2026. First, he exercised an incentive stock option (transaction code M) covering 4,000 shares of common stock at a conversion price of $0.56, bringing his total directly held common stock to 74,733 shares at that point.

Immediately following the exercise, the filing reports that Alpern sold (transaction code S) all 4,000 of those shares at a weighted average price of $20.7658 per share. The shares were sold in multiple transactions at prices ranging from $20.61 to $21.38, inclusive. The filing notes that Alpern "undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range." After the sale, his directly held common stock totaled 70,733 shares.

The filing also discloses that both transactions were executed under a Rule 10b5-1 trading plan that Alpern adopted on February 23, 2026. The exercised incentive stock option had a vesting schedule under which 25% of total shares vested on August 26, 2020, with 1/48th of total shares vesting monthly for three years beginning September 26, 2020, and an expiration date of October 23, 2029. Following the option exercise and disposal, 49,000 incentive stock options remain directly held by Alpern.

What Was Disclosed

The Form 4 filed September 3, 2026 discloses that Arteris VP and General Counsel Paul L. Alpern exercised 4,000 incentive stock options at $0.56 and sold 4,000 shares at a weighted average of $20.7658 on September 1, 2026, under a pre-established 10b5-1 plan.